News

December 4, 2019December 4, 2019

MyGut Crohn’s and Colitis Canada App Empowers IBD Patients to Manage Health, Wellness

News

Aiming to improve the lives of the more than 250,000 Canadian residents living with inflammatory bowel disease (IBD), Crohn’s and Colitis Canada is launching a health and wellness empowerment app. ... Read more

December 2, 2019December 2, 2019

Abivax’s Phase 2b Trial Testing ABX464 for Ulcerative Colitis Cleared to Add French Sites

News

France’s National Agency for the Safety of Medicine and Health Products (ANSM) has cleared the inclusion of French study sites for Abivax‘s new Phase 2b clinical trial, intended to evaluate ... Read more

November 25, 2019November 25, 2019

Thetis Receives Funds From Crohn’s & Colitis Foundation to Further Develop TP-317 for IBD

News

The Crohn’s & Colitis Foundation is providing funding support to Thetis Pharmaceuticals for the continuing development of the novel oral therapy TP-317 for the treatment of inflammatory bowel disease (IBD). ... Read more

November 22, 2019November 22, 2019

FDA Approves Pfizer’s Abrilada, Biosimilar to Humira, for IBD and Other Inflammatory Disorders

News

Abrilada (adalimumab-afzb), a biosimilar to Humira (adalimumab), has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of seven inflammatory disorders, including adult Crohn’s disease and ... Read more

November 18, 2019November 18, 2019

Mice Exposed to High-Sugar Diet More Susceptible to IBD, Especially Colitis, Study Shows

News

A high-sugar diet may increase susceptibility to inflammatory bowel diseases (IBD), and specifically colitis, a study in mice suggests. Titled “A high-sugar diet rapidly enhances susceptibility to colitis via depletion ... Read more

November 15, 2019November 15, 2019

Finch and Takeda Expand Their Collaboration to Target Crohn’s Treatment Development

News

Finch Therapeutics and Takeda Pharmaceutical are joining forces to develop a treatment for Crohn’s disease — expanding their partnership in their development program for inflammatory bowel disease (IBD), which includes an ... Read more

November 13, 2019November 13, 2019

Feeding Infants the Probiotic Bifidobacterium infantis Led to Significantly Lower Intestinal Inflammation, Study Shows

News

Intestinal inflammation was significantly lower in infants that were fed the bacteria B. infantis along with breast milk than in infants that were solely breastfed, a study shows. These findings ... Read more

November 11, 2019November 11, 2019

1st Patient Dosed in Phase 2 Trial of Investigational PTG-200 for Crohn’s Disease, Protagonist Announces

News

The first patient has been dosed in Protagonist Therapeutics’ Phase 2 clinical trial of PTG-200 for the treatment of moderate to severe Crohn’s disease, the company announced. Still recruiting at ... Read more

November 8, 2019November 8, 2019

Endoscopy Given IBD Patients Within 6 Months of Starting Biologic May Limit Complications, Study Says

News

An GI tract examination by endoscopy given within six months of starting treatment with a biologic may lessen the risk of complications in people with inflammatory bowel disease (IBD), a study found. ... Read more

November 6, 2019November 6, 2019

European 3TR Project Unites Experts in Effort to Make Treatment More Personal and Effective

News

A new public-private initiative brings academic and industry researchers from 15 European countries together in a large-scale effort to understand differences and commonalities in seven immune-mediated and inflammatory diseases, including ... Read more